# Physical Activity Promotion and Clinical Remission in Severe Asthma

> **NCT07735494** · NA · RECRUITING · sponsor: **University of Leeds** · enrollment: 140 (estimated)

## Conditions studied

- Severe Asthma

## Interventions

- **BEHAVIORAL:** Physical activity promotion
- **DRUG:** Tezepelumab

## Key facts

- **NCT ID:** NCT07735494
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-12-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735494, "Physical Activity Promotion and Clinical Remission in Severe Asthma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07735494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
